Literature DB >> 25351777

Detection of TRIM32 deletions in LGMD patients analyzed by a combined strategy of CGH array and massively parallel sequencing.

Juliette Nectoux1, Rafael de Cid2, Sylvain Baulande3, France Leturcq4, Jon Andoni Urtizberea5, Isabelle Penisson-Besnier6, Aleksandra Nadaj-Pakleza6, Carinne Roudaut2, Audrey Criqui3, Lucie Orhant7, Delphine Peyroulan8, Raba Ben Yaou9, Isabelle Nelson9, Anna Maria Cobo5, Marie-Christine Arné-Bes10, Emmanuelle Uro-Coste10, Patrick Nitschke11, Mireille Claustres12, Gisèle Bonne13, Nicolas Lévy14, Jamel Chelly1, Isabelle Richard2, Mireille Cossée12.   

Abstract

Defects in TRIM32 were reported in limb-girdle muscular dystrophy type 2H (LGMD2H), sarcotubular myopathies (STM) and in Bardet-Biedl syndrome. Few cases have been described to date in LGMD2H/STM, but this gene is not systematically analysed because of the absence of specific signs and difficulties in protein analysis. By using high-throughput variants screening techniques, we identified variants in TRIM32 in two patients presenting nonspecific LGMD. We report the first case of total inactivation by homozygous deletion of the entire TRIM32 gene. Of interest, the deletion removes part of the ASTN2 gene, a large gene in which TRIM32 is nested. Despite the total TRIM32 gene inactivation, the patient does not present a more severe phenotype. However, he developed a mild progressive cognitive impairment that may be related to the loss of function of ASTN2 because association between ASTN2 heterozygous deletions and neurobehavioral disorders was previously reported. Regarding genomic characteristics at breakpoint of the deleted regions of TRIM32, we found a high density of repeated elements, suggesting a possible hotspot. These observations illustrate the importance of high-throughput technologies for identifying molecular defects in LGMD, confirm that total loss of function of TRIM32 is not associated with a specific phenotype and that TRIM32/ASTN2 inactivation could be associated with cognitive impairment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25351777      PMCID: PMC4463509          DOI: 10.1038/ejhg.2014.223

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  23 in total

1.  Validation of comparative genomic hybridization arrays for the detection of genomic rearrangements of the calpain-3 and dysferlin genes.

Authors:  M Bartoli; P Nègre; N Wein; P Bourgeois; C Pécheux; N Lévy; Martin Krahn
Journal:  Clin Genet       Date:  2012-01       Impact factor: 4.438

2.  CGHweb: a tool for comparing DNA copy number segmentations from multiple algorithms.

Authors:  Weil Lai; Vidhu Choudhary; Peter J Park
Journal:  Bioinformatics       Date:  2008-02-22       Impact factor: 6.937

3.  Neural stem cells maintain their stemness through protein kinase C ζ-mediated inhibition of TRIM32.

Authors:  Anna-Lena Hillje; Maik M A Worlitzer; Thomas Palm; Jens C Schwamborn
Journal:  Stem Cells       Date:  2011-09       Impact factor: 6.277

4.  Astn2, a novel member of the astrotactin gene family, regulates the trafficking of ASTN1 during glial-guided neuronal migration.

Authors:  Perrin M Wilson; Robert H Fryer; Yin Fang; Mary E Hatten
Journal:  J Neurosci       Date:  2010-06-23       Impact factor: 6.167

5.  TRIM32 promotes retinoic acid receptor α-mediated differentiation in human promyelogenous leukemic cell line HL60.

Authors:  Tomonobu Sato; Fumihiko Okumura; Akihiro Iguchi; Tadashi Ariga; Shigetsugu Hatakeyama
Journal:  Biochem Biophys Res Commun       Date:  2011-12-11       Impact factor: 3.575

6.  A patient with limb girdle muscular dystrophy carries a TRIM32 deletion, detected by a novel CGH array, in compound heterozygosis with a nonsense mutation.

Authors:  M Neri; R Selvatici; C Scotton; C Trabanelli; A Armaroli; D De Grandis; N Levy; F Gualandi; A Ferlini
Journal:  Neuromuscul Disord       Date:  2013-03-28       Impact factor: 4.296

7.  Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin.

Authors:  Elena Kudryashova; Dmitri Kudryashov; Irina Kramerova; Melissa J Spencer
Journal:  J Mol Biol       Date:  2005-10-10       Impact factor: 5.469

8.  A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder.

Authors:  Ke-Sheng Wang; Xue-Feng Liu; Nagesh Aragam
Journal:  Schizophr Res       Date:  2010-12       Impact factor: 4.939

9.  Use of SNP array analysis to identify a novel TRIM32 mutation in limb-girdle muscular dystrophy type 2H.

Authors:  Mireille Cossée; Clotilde Lagier-Tourenne; Claire Seguela; Michel Mohr; France Leturcq; Hulya Gundesli; Jamel Chelly; Christine Tranchant; Michel Koenig; Jean-Louis Mandel
Journal:  Neuromuscul Disord       Date:  2009-03-19       Impact factor: 4.296

10.  Regulatory feedback loop between TP73 and TRIM32.

Authors:  L Gonzalez-Cano; A-L Hillje; S Fuertes-Alvarez; M M Marques; A Blanch; R W Ian; M S Irwin; J C Schwamborn; M C Marín
Journal:  Cell Death Dis       Date:  2013-07-04       Impact factor: 8.469

View more
  9 in total

1.  Drosophila TRIM32 cooperates with glycolytic enzymes to promote cell growth.

Authors:  Simranjot Bawa; David S Brooks; Kathryn E Neville; Marla Tipping; Md Abdul Sagar; Joseph A Kollhoff; Geetanjali Chawla; Brian V Geisbrecht; Jason M Tennessen; Kevin W Eliceiri; Erika R Geisbrecht
Journal:  Elife       Date:  2020-03-30       Impact factor: 8.140

2.  Laminin α2 Deficiency-Related Muscular Dystrophy Mimicking Emery-Dreifuss and Collagen VI related Diseases.

Authors:  Isabelle Nelson; Tanya Stojkovic; Valérie Allamand; France Leturcq; Henri-Marc Bécane; Dominique Babuty; Annick Toutain; Christophe Béroud; Pascale Richard; Norma B Romero; Bruno Eymard; Rabah Ben Yaou; Gisèle Bonne
Journal:  J Neuromuscul Dis       Date:  2015-09-02

3.  Thin is required for cell death in the Drosophila abdominal muscles by targeting DIAP1.

Authors:  Kumar Vishal; Simranjot Bawa; David Brooks; Kenneth Bauman; Erika R Geisbrecht
Journal:  Cell Death Dis       Date:  2018-07-03       Impact factor: 8.469

4.  Hybrid Capture-Based Next Generation Sequencing and Its Application to Human Infectious Diseases.

Authors:  Maxime Gaudin; Christelle Desnues
Journal:  Front Microbiol       Date:  2018-11-27       Impact factor: 5.640

5.  Novel TRIM32 mutation in sarcotubular myopathy.

Authors:  Chiara Panicucci; Monica Traverso; Serena Baratto; Chiara Romeo; Michele Iacomino; Chiara Gemelli; Alberto Tagliafico; Paolo Broda; Federico Zara; Claudio Bruno; Carlo Minetti; Chiara Fiorillo
Journal:  Acta Myol       Date:  2019-03-01

6.  Altered myogenesis and premature senescence underlie human TRIM32-related myopathy.

Authors:  E Servián-Morilla; M Cabrera-Serrano; E Rivas-Infante; A Carvajal; P J Lamont; A L Pelayo-Negro; G Ravenscroft; R Junckerstorff; J M Dyke; S Fletcher; A M Adams; F Mavillard; M A Fernández-García; J L Nieto-González; N G Laing; C Paradas
Journal:  Acta Neuropathol Commun       Date:  2019-03-01       Impact factor: 7.801

7.  Extending the clinical and mutational spectrum of TRIM32-related myopathies in a non-Hutterite population.

Authors:  Katherine Johnson; Willem De Ridder; Ana Töpf; Marta Bertoli; Lauren Phillips; Peter De Jonghe; Jonathan Baets; Tine Deconinck; Vidosava Rakocevic Stojanovic; Stojan Perić; Hacer Durmus; Shirin Jamal-Omidi; Shahriar Nafissi; Tiziana Mongini; Anna Łusakowska; Mark Busby; James Miller; Fiona Norwood; Judith Hudson; Rita Barresi; Monkol Lek; Daniel G MacArthur; Volker Straub
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-06-19       Impact factor: 10.154

Review 8.  TRIM32 and Malin in Neurological and Neuromuscular Rare Diseases.

Authors:  Lorena Kumarasinghe; Lu Xiong; Maria Adelaida Garcia-Gimeno; Elisa Lazzari; Pascual Sanz; Germana Meroni
Journal:  Cells       Date:  2021-04-06       Impact factor: 6.600

Review 9.  A novel homozygous exon2 deletion of TRIM32 gene in a Chinese patient with sarcotubular myopathy: A case report and literature review.

Authors:  Xiao-Jing Wei; Jing Miao; Zhi-Xia Kang; Yan-Lu Gao; Zi-Yi Wang; Xue-Fan Yu
Journal:  Bosn J Basic Med Sci       Date:  2021-08-01       Impact factor: 3.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.